These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1653141)

  • 1. A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group.
    Eur Neurol; 1991; 31(5):332-8. PubMed ID: 1653141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group.
    Eur Neurol; 1991; 31(5):306-13. PubMed ID: 1653138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
    Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group.
    Eur Neurol; 1991; 31(5):300-5. PubMed ID: 1653137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
    Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
    N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute migraine with subcutaneous sumatriptan.
    Cady RK; Wendt JK; Kirchner JR; Sargent JD; Rothrock JF; Skaggs H
    JAMA; 1991 Jun; 265(21):2831-5. PubMed ID: 1851894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous sumatriptan in the acute treatment of migraine. Sumatriptan International Study Group.
    Ensink FB
    J Neurol; 1991; 238 Suppl 1():S66-9. PubMed ID: 1646291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
    Diamond S; Elkind A; Jackson RT; Ryan R; DeBussey S; Asgharnejad M
    Arch Fam Med; 1998; 7(3):234-40. PubMed ID: 9596457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group.
    Eur Neurol; 1991; 31(5):314-22. PubMed ID: 1653139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine.
    Peikert A; Becker WJ; Ashford EA; Dahlof C; Hassani H; Salonen RJ
    Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral sumatriptan in acute migraine.
    Goadsby PJ; Zagami AS; Donnan GA; Symington G; Anthony M; Bladin PF; Lance JW
    Lancet; 1991 Sep; 338(8770):782-3. PubMed ID: 1681162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of migraine attacks with sumatriptan.
    Subcutaneous Sumatriptan International Study Group
    N Engl J Med; 1991 Aug; 325(5):316-21. PubMed ID: 1647495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group.
    Bousser MG; D'Allens H; Richard A
    J Intern Med; 1993 Aug; 234(2):211-6. PubMed ID: 8393474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study.
    Djupesland PG; Docekal P;
    Cephalalgia; 2010 Aug; 30(8):933-42. PubMed ID: 20656704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan injection is superior to placebo in the acute treatment of migraine--with regard to both efficacy and general well-being.
    Dahlöf C; Edwards C; Toth A
    Cephalalgia; 1992 Aug; 12(4):214-20. PubMed ID: 1326404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.